Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the“Company”) a leader in the development of oral peptides and small therapeutic proteins, today reported financial results and key business updates for ...
The decrease in revenues from installment service fee was mainly due to the decrease in volume of both new and outstanding small and medium enterprises ("SMEs") loans under current marketing ...
Rather than building a network itself by putting fiber into the ground, which we think often fails to justify the steep expense due to oversupply over many geographies, Cogent signed long-term leases ...
Interest expense was $42.5 million for the quarter ended September 30, 2024, compared to $28.3 million for the quarter ended September 30, 2023. The higher expenses were primarily driven by the ...